• FirefoxInstall the new Firefox »
  •  Dow Down 0.98% Nasdaq Down 0.61%

    Oncothyreon Inc (ONTY)

    -NasdaqGS
    1.57 Down 0.04(2.18%) 11:21AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:1.61
    Open:1.60
    Bid:1.56 x 4300
    Ask:1.57 x 4100
    1y Target Est:4.00
    Beta:1.52
    Next Earnings Date:N/A
    Day's Range:1.56 - 1.60
    52wk Range:1.48 - 4.08
    Volume:232,007
    Avg Vol (3m):910,440
    Market Cap:143.74M
    P/E (ttm):N/A
    EPS (ttm):-0.40
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ONTY

    Comparison

    Symbol% ChgMkt Cap
    ONTYDown 2.18%143.74M
    GSKDown 1.34%112.96B
    RHHBYUp 1.27%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:08-May-95

    Analysts

    Annual EPS Est (Dec-14) :-0.39
    Quarterly EPS Est (Dec-14) :-0.09
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Oncothyreon Inc, a clinical-stage biopharmaceutical company, develops therapeutic products for the treatment of cancer. Its product candidate includes Tecemotide, a vaccine for the treatment of non-small cell lung cancer. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback